Immune checkpoint inhibitors is currently the most important anti-tumor therapy, but immunotherapy resistance affects the therapeutic effect. This article reviews the related mechanisms of immune checkpoint inhibitor resistance and the mechanisms of the relationship between gut microbiota and immune checkpoint inhibitor resistance. By improving gut microbiota to increase treatment sensitivity and alleviate immunotherapy resistance, an effective method has been explored to address immune checkpoint inhibitor resistance.